Wang Luhua, president of Shenzhen Hospital of Cancer Hospital of Chinese Academy of Medical Sciences
How far are Shenzhen people from cancer?
According to the 2020 Shenzhen New Malignant Tumor Ranking released by the Shenzhen Chronic Disease Prevention and Control Center, a total of 30,808 new malignant tumors were reported by the resident population of Shenzhen in 2020, an increase of 2,079 cases over the previous year, an increase of 7.24%.
Based on 365 days a year, an average of 84 new cases are issued per day, and more than 3 cases per hour.
In the country's first medical observation documentary program "My White Coat 2: Ace Department", a patient with advanced cholangiocarcinoma had already made his own judgment before the doctor opened his mouth: "Basically there is no hope." ”
Cancer = terminal illness?
On December 17-19, the 2021 China Cancer Early Diagnosis and Early Diagnosis and Standardized Diagnosis and Treatment Conference and the 9th National Cancer Center Academic Annual Conference, the highest "dan" tumor prevention and control conference in China, were moved to Shenzhen for the first time, and the "Southern Branch of the National Cancer Center" was officially settled in Shenzhen.
At this conference, the "national team" of cancer treatment conveyed a concept to the society: it is preventable and controllable, and cancer is not a terminal disease!
Top national cancer prevention and treatment experts gathered in Shenzhen to bring the 2021 "report card"
In 2021, the central hospital received 44 national natural science funding; in the opening year of the "14th Five-Year Plan", a total of 6 key R&D program projects were funded; at the end of this year, 558 papers were published, including 337 SCI journals, with a total impact factor of 2012.853, of which 30 high-level articles (more than 10 points) were published...
At this conference, the National Cancer Center disclosed a number of achievements. Leaders of government departments in the field of cancer prevention and control, heads of cancer prevention and control institutions at all levels, and well-known experts and scholars from the perspective of the strategic interpretation of Healthy China, the construction planning of national medical centers and regional medical centers, the construction of national cancer prevention and control platforms, cancer monitoring and early diagnosis and treatment, quality control of clinical diagnosis and treatment of tumors, frontier progress of tumor research, and multidisciplinary diagnosis and treatment of tumors, discussed the opportunities and challenges facing cancer prevention and control.
The 3-day conference, through online and offline forms, organized a number of special reports, many experts and scholars shared the latest academic research and progress in cancer prevention and control online and offline, and the "strongest brain" staged a collision of ideas here.
The reporter learned that in order to effectively achieve the goal of improving the 5-year survival rate of cancer proposed by "Healthy China 2030", the National Cancer Center has made a lot of efforts in early tumor screening. In recent years, the survival rate of cancer patients in China has gradually increased.
According to the statistics of the National Cancer Center, in 2012-2015, the 5-year survival rate of all types of cancer patients in China rose from 30.9% in 2003-2005 to 40.5%. This is mainly due to the increasing health expenditure of our government, the improvement of medical technology, the control of cancer-related risk factors, and the early diagnosis and treatment of cancer.
It should be emphasized that cancer screening and early diagnosis and treatment are one of the effective means to reduce the mortality rate of cancer patients and improve the survival rate.
Taking the highest incidence of lung cancer in China as an example, the 5-year survival rate of stage I lung cancer can be more than 80%, while the 5-year survival rate of stage IV lung cancer that has metastasized is less than 10%. In addition, a type of cancer represented by colorectal cancer has a relatively clear precancerous lesion, and early detection of precancerous lesions and intervention can prevent the occurrence of cancer and reduce the incidence of cancer.
A large number of research practices at home and abroad have also confirmed that screening and early diagnosis and treatment of specific cancers can reduce cancer mortality and improve survival rates.
At present, the Chinese government has carried out a series of public health projects for cancer screening and early diagnosis and early treatment by relying on the central financial transfer payment, including the "Urban Cancer Early Diagnosis and Early Treatment Project", "Rural Cancer Early Diagnosis and Early Treatment Project", "Huai River Basin Cancer Early Diagnosis and Early Treatment Project", etc., and achieved good social benefits.
The "Southern Branch of the National Cancer Center" was settled, and the early diagnosis and early treatment project was rolled out in Shenzhen
On the day of the opening ceremony, the "Southern Branch of the National Cancer Center" was officially unveiled, announcing that the sub-center was settled in Shenzhen.
This is a major measure for the National Cancer Center to help Shenzhen further consolidate the foundation of cancer prevention and control work and effectively improve the health level of the people.
"While improving the ability of medical services, we will also actively do a good job in popularizing the health knowledge of cancer prevention and treatment, focusing on the control and intervention of risk factors in the population, the promotion and application of appropriate technologies for screening and early diagnosis and early treatment, and the standardization of screening and early diagnosis and early treatment, so as to continuously improve the people's awareness of cancer prevention and anti-cancer." Wang Luhua, president of the Shenzhen Hospital of the Cancer Hospital of the Chinese Academy of Medical Sciences, said.
Since 2017, the National Cancer Center has fully supported the construction and development of the Shenzhen Hospital of the Cancer Hospital of the Chinese Academy of Medical Sciences, promoted the landing of major public health special urban cancer early diagnosis and early treatment projects in Shenzhen, and the Southern Branch of the National Malignant Tumor Clinical Medical Research Center was listed in Shenzhen.
Relying on the Shenzhen Hospital of the Cancer Hospital of the Chinese Academy of Medical Sciences and the support of the National Cancer Center, the South Branch Center will continue to promote the coverage of major public health special urban cancer early diagnosis and early treatment projects, and play a leading role in south China in the construction of tumor registration and tumor resource platform, the exploration of cancer prevention and control service models and the improvement of regional cancer comprehensive prevention and treatment service capabilities.
North and Shenzhen share technology, talents and discipline construction, and Shenzhen patients can be treated on the spot
The treatment of tumor diseases, especially malignant tumors, is difficult to treat, which seriously endangers the health of the people.
For the management of tumor diagnosis and treatment, the National Health Commission attaches great importance to it, and has formulated and issued a series of departmental regulations and normative documents for the whole process of cancer diagnosis and treatment, clarifying and emphasizing relevant requirements many times. On October 15, 2021, the National Health Commission issued the Notice on Printing and Distributing the Action Plan for Improving the Quality of Cancer Diagnosis and Treatment, which once again emphasized and further clarified the specific requirements for tumor diagnosis and treatment management.
At the same time, the National Cancer Center has always cared, helped and supported the health cause of Shenzhen.
Since 2016, the National Cancer Center has promoted the "Early Diagnosis and Early Treatment of Urban Cancer" project in Shenzhen, and carried out free screening for residents for the five most frequent "key cancers" in China - lung cancer, liver cancer, upper gastrointestinal cancer, colorectal cancer and breast cancer.
On March 18, 2017, The Shenzhen Hospital of the Cancer Hospital of the Chinese Academy of Medical Sciences was officially inaugurated, which is a public tertiary cancer specialty hospital jointly built by the Shenzhen Municipal Government and the Cancer Hospital of the Chinese Academy of Medical Sciences, adopting the management mode of "one hospital and two districts", and the two hospitals in Beijing and Shenzhen fully share the medical and management resources of oncology specialties such as technology, talents and discipline construction.
Relying on the strong support of the Cancer Hospital of the Chinese Academy of Medical Sciences, the Shenzhen Hospital of the Cancer Hospital of the Chinese Academy of Medical Sciences has developed rapidly and comprehensively, and the goal of opening 800 inpatient beds has been exceeded within 2 years of opening. The ability to treat patients with difficult, acute and critical tumors is outstanding, and the patients who come to the clinic cover all provinces, municipalities and autonomous regions in the country and Hong Kong, Macao and Taiwan, which has changed the path of Shenzhen tumor patients to seek medical treatment in "north, Shanghai and Guangzhou".
[Reporter] Huang Sihua Liu Shan
【Video】Wang Lyric
【Author】 Huang Sihua; Liu Shan
【Source】 Southern Press Media Group South + client